Press Releases

Tools being developed by C-Path’s CURE Drug Repurposing Collaboratory will help incorporate adaptive platform trial protocol

Sorin Fedeles, Ph.D., MBA to serve as new Executive Director TUCSON, Ariz., October 14, 2021 – Critical Path Institute (C-Path)

LONDON, Canada and TUCSON, Ariz., U.S., September 30, 2021, 2021 — Critical Path Institute (C-Path) and Pulse Infoframe announce

TUCSON, Ariz., September 16, 2021 — Critical Path Institute (C-Path) today announced the appointment of Jonathan M. Davis, M.D.,

C-Path, NORD and FDA host annual meeting, demonstration and launch of new rare disease data and analytics platform. TUCSON, Ariz.

RARE-X and Critical Path Institute align on their mission and commitment for data sharing to improve rare disease research TUCSON,

C-Path, NORD and FDA have spent two years building the platform set to launchSept. 14 at the 2021 RDCA-DAP Workshop. TUCSON, Ariz.

Sonya Eremenco will lead C-Path’s PRO Consortium TUCSON, Ariz., August 5, 2021— Critical Path Institute (C-Path) announced it

Global stakeholders come together to collaborate with urgency to address unmet needs for Parkinson’s therapies. TUCSON, Ariz., J